During the past decade, Charlottesville Medical Research conducted 50 clinical trials. In the 10-year time frame, 50 clinical trials started and 50 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 33 clinical trials were completed. i.e. 183.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Charlottesville Medical Research" #1 sponsor was "Pfizer" with 15 trials, followed by "Allergan" with 5 trials sponsored, "Shire" with 4 trials sponsored, "Abbott" with 3 trials sponsored and "Braintree Laboratories" with 3 trials sponsored. Other sponsors include 59 different institutions and companies that sponsored additional 52 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Charlottesville Medical Research" #1 collaborator was "Premier Research Group plc" with 3 trials as a collaborator, "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "Gilead Sciences" with 2 trials as a collaborator, "Ironwood Pharmaceuticals, Inc." with 2 trials as a collaborator and "CS Lifescience" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Charlottesville Medical Research" are "Osteoarthritis" (10 trials), "Migraine" (9 trials), "Crohn's Disease" (6 trials), "Osteoarthritis, Hip" (5 trials) and "Arthritis" (4 trials). Many other conditions were trialed in "Charlottesville Medical Research" in a lesser frequency.

Most popular intervention types in "Charlottesville Medical Research" are "Drug" (69 trials), "Biological" (19 trials), "Device" (5 trials), "Other" (5 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (28 trials), "placebo" (5 trials), "Atogepant" (3 trials), "Diclofenac" (3 trials) and "Dihydroergotamine" (3 trials). Other intervention names were less common.

The vast majority of trials in "Charlottesville Medical Research" are 91 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Charlottesville Medical Research". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 74 completed trials in Charlottesville Medical Research, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Charlottesville Medical Research, 0 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 65 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 2 trials that are defined as “Not Applicable".